229 related articles for article (PubMed ID: 23166318)
1. Differential regulation of extracellular tissue inhibitor of metalloproteinases-3 levels by cell membrane-bound and shed low density lipoprotein receptor-related protein 1.
Scilabra SD; Troeberg L; Yamamoto K; Emonard H; Thøgersen I; Enghild JJ; Strickland DK; Nagase H
J Biol Chem; 2013 Jan; 288(1):332-42. PubMed ID: 23166318
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the interaction between tissue inhibitor of metalloproteinases-3 (TIMP-3) and low density lipoprotein receptor-related protein-1 (LRP-1): Development of a "TRAP" to increase levels of TIMP-3 in the tissue.
Scilabra SD; Yamamoto K; Pigoni M; Sakamoto K; Müller SA; Papadopoulou A; Lichtenthaler SF; Troeberg L; Nagase H; Kadomatsu K
Matrix Biol; 2017 May; 59():69-79. PubMed ID: 27476612
[TBL] [Abstract][Full Text] [Related]
3. TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1.
Carreca AP; Pravatà VM; Markham M; Bonelli S; Murphy G; Nagase H; Troeberg L; Scilabra SD
Sci Rep; 2020 Jul; 10(1):12067. PubMed ID: 32694578
[TBL] [Abstract][Full Text] [Related]
4. Increased TIMP-3 expression alters the cellular secretome through dual inhibition of the metalloprotease ADAM10 and ligand-binding of the LRP-1 receptor.
Scilabra SD; Pigoni M; Pravatá V; Schätzl T; Müller SA; Troeberg L; Lichtenthaler SF
Sci Rep; 2018 Oct; 8(1):14697. PubMed ID: 30279425
[TBL] [Abstract][Full Text] [Related]
5. Sulfated glycosaminoglycans control the extracellular trafficking and the activity of the metalloprotease inhibitor TIMP-3.
Troeberg L; Lazenbatt C; Anower-E-Khuda MF; Freeman C; Federov O; Habuchi H; Habuchi O; Kimata K; Nagase H
Chem Biol; 2014 Oct; 21(10):1300-1309. PubMed ID: 25176127
[TBL] [Abstract][Full Text] [Related]
6. Engineered Tissue Inhibitor of Metalloproteinases-3 Variants Resistant to Endocytosis Have Prolonged Chondroprotective Activity.
Doherty CM; Visse R; Dinakarpandian D; Strickland DK; Nagase H; Troeberg L
J Biol Chem; 2016 Oct; 291(42):22160-22172. PubMed ID: 27582494
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein receptor-related protein-1 mediates endocytic clearance of tissue inhibitor of metalloproteinases-1 and promotes its cytokine-like activities.
Thevenard J; Verzeaux L; Devy J; Etique N; Jeanne A; Schneider C; Hachet C; Ferracci G; David M; Martiny L; Charpentier E; Khrestchatisky M; Rivera S; Dedieu S; Emonard H
PLoS One; 2014; 9(7):e103839. PubMed ID: 25075518
[TBL] [Abstract][Full Text] [Related]
8. Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2.TIMP-2 complex through a thrombospondin-independent mechanism.
Emonard H; Bellon G; Troeberg L; Berton A; Robinet A; Henriet P; Marbaix E; Kirkegaard K; Patthy L; Eeckhout Y; Nagase H; Hornebeck W; Courtoy PJ
J Biol Chem; 2004 Dec; 279(52):54944-51. PubMed ID: 15489233
[TBL] [Abstract][Full Text] [Related]
9. MMP-13 is constitutively produced in human chondrocytes and co-endocytosed with ADAMTS-5 and TIMP-3 by the endocytic receptor LRP1.
Yamamoto K; Okano H; Miyagawa W; Visse R; Shitomi Y; Santamaria S; Dudhia J; Troeberg L; Strickland DK; Hirohata S; Nagase H
Matrix Biol; 2016 Dec; 56():57-73. PubMed ID: 27084377
[TBL] [Abstract][Full Text] [Related]
10. Shedding of low-density lipoprotein receptor–related protein-1 in acute respiratory distress syndrome.
Wygrecka M; Wilhelm J; Jablonska E; Zakrzewicz D; Preissner KT; Seeger W; Guenther A; Markart P
Am J Respir Crit Care Med; 2011 Aug; 184(4):438-48. PubMed ID: 21471105
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Shedding of Low-Density Lipoprotein Receptor-Related Protein 1 Reverses Cartilage Matrix Degradation in Osteoarthritis.
Yamamoto K; Santamaria S; Botkjaer KA; Dudhia J; Troeberg L; Itoh Y; Murphy G; Nagase H
Arthritis Rheumatol; 2017 Jun; 69(6):1246-1256. PubMed ID: 28235248
[TBL] [Abstract][Full Text] [Related]
12. Cellular uptake of proMMP-2:TIMP-2 complexes by the endocytic receptor megalin/LRP-2.
Johanns M; Lemoine P; Janssens V; Grieco G; Moestrup SK; Nielsen R; Christensen EI; Courtoy PJ; Emonard H; Marbaix E; Henriet P
Sci Rep; 2017 Jun; 7(1):4328. PubMed ID: 28659595
[TBL] [Abstract][Full Text] [Related]
13. Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function.
Selvais C; D'Auria L; Tyteca D; Perrot G; Lemoine P; Troeberg L; Dedieu S; Noël A; Nagase H; Henriet P; Courtoy PJ; Marbaix E; Emonard H
FASEB J; 2011 Aug; 25(8):2770-81. PubMed ID: 21518850
[TBL] [Abstract][Full Text] [Related]
14. Suramin Inhibits Osteoarthritic Cartilage Degradation by Increasing Extracellular Levels of Chondroprotective Tissue Inhibitor of Metalloproteinases 3.
Chanalaris A; Doherty C; Marsden BD; Bambridge G; Wren SP; Nagase H; Troeberg L
Mol Pharmacol; 2017 Oct; 92(4):459-468. PubMed ID: 28798097
[TBL] [Abstract][Full Text] [Related]
15. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
[TBL] [Abstract][Full Text] [Related]
16. Extracellular regulation of metalloproteinases.
Yamamoto K; Murphy G; Troeberg L
Matrix Biol; 2015; 44-46():255-63. PubMed ID: 25701651
[TBL] [Abstract][Full Text] [Related]
17. Sulfated Hyaluronan Alters the Interaction Profile of TIMP-3 with the Endocytic Receptor LRP-1 Clusters II and IV and Increases the Extracellular TIMP-3 Level of Human Bone Marrow Stromal Cells.
Rother S; Samsonov SA; Hempel U; Vogel S; Moeller S; Blaszkiewicz J; Köhling S; Schnabelrauch M; Rademann J; Pisabarro MT; Hintze V; Scharnweber D
Biomacromolecules; 2016 Oct; 17(10):3252-3261. PubMed ID: 27610455
[TBL] [Abstract][Full Text] [Related]
18. Metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 ectodomain decreases endocytic clearance of endometrial matrix metalloproteinase-2 and -9 at menstruation.
Selvais C; Gaide Chevronnay HP; Lemoine P; Dedieu S; Henriet P; Courtoy PJ; Marbaix E; Emonard H
Endocrinology; 2009 Aug; 150(8):3792-9. PubMed ID: 19406945
[TBL] [Abstract][Full Text] [Related]
19. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.
Zhao H; Bernardo MM; Osenkowski P; Sohail A; Pei D; Nagase H; Kashiwagi M; Soloway PD; DeClerck YA; Fridman R
J Biol Chem; 2004 Mar; 279(10):8592-601. PubMed ID: 14681236
[TBL] [Abstract][Full Text] [Related]
20. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface.
Itoh Y; Ito A; Iwata K; Tanzawa K; Mori Y; Nagase H
J Biol Chem; 1998 Sep; 273(38):24360-7. PubMed ID: 9733724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
